IMMUCELL CORP /DE/ Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Immucell Corp /De/ quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2017 to Q4 2024.
  • Immucell Corp /De/ Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $68.9K, a 31.6% decline year-over-year.
  • Immucell Corp /De/ Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $326K, a 11.7% decline year-over-year.
  • Immucell Corp /De/ annual Share-based Payment Arrangement, Expense for 2024 was $326K, a 11.7% decline from 2023.
  • Immucell Corp /De/ annual Share-based Payment Arrangement, Expense for 2023 was $369K, a 38.5% increase from 2022.
  • Immucell Corp /De/ annual Share-based Payment Arrangement, Expense for 2022 was $266K, a 84.5% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $326K $68.9K -$31.8K -31.6% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 $357K $77.6K -$18.9K -19.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $376K $98K +$22.4K +29.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $354K $81.1K -$15K -15.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $369K $101K +$35.3K +53.9% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 $334K $96.4K +$11.3K +13.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $322K $75.7K +$14K +22.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $308K $96.1K +$42K +77.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $266K $65.4K +$24.5K +59.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $242K $85.1K +$39.6K +87.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $202K $61.6K +$38.4K +165% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $164K $54.1K +$19.5K +56.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $144K $40.9K -$15.8K -27.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $160K $45.5K -$16.9K -27.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 $177K $23.3K -$33.4K -58.9% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-11-21
Q1 2021 $210K $34.6K -$42.8K -55.3% Jan 1, 2021 Mar 31, 2021 10-Q/A 2022-11-21
Q4 2020 $253K $56.7K -$34.9K -38.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $288K $62.4K -$6.26K -9.11% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $294K $56.6K -$13.4K -19.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $308K $77.4K -$5.43K -6.56% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $313K $91.6K +$5.26K +6.09% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 $308K $68.7K -$21.1K -23.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $329K $70.1K -$26.9K -27.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $356K $82.8K +$11.8K +16.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $344K $86.3K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $89.7K +$42.8K +91.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $96.9K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $71K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q3 2017 $46.9K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.